We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Humana
HUM
$46.9B
| $12M | 0.16% |
29,016
-23,441
| -45% | -$9.43M |
|
152
Hershey
HSY
$35.4B
| $12M | 0.16% |
83,590
-48,352
| -37% | -$6.86M |
|
153
IQVIA
IQV
$34.8B
| $11.8M | 0.16% |
75,072
+49,935
| +199% | +$7.83M |
|
154
Centene
CNC
$31.2B
| $11.7M | 0.16% |
201,051
+72,830
| +57% | +$4.52M |
|
155
Cintas
CTAS
$82.3B
| $11.7M | 0.16% |
140,168
-34,004
| -20% | -$2.62M |
|
156
Labcorp
LH
$24.3B
| $11.5M | 0.16% |
71,147
-23,840
| -25% | -$3.78M |
|
157
Thor Industries
THO
$3.98B
| $11.5M | 0.15% |
120,226
+104,683
| +674% | +$10.8M |
|
158
Kraft Heinz
KHC
$30.2B
| $11.2M | 0.15% |
+375,113
| New | +$12.5M |
|
159
Advance Auto Parts
AAP
$3.27B
| $11.2M | 0.15% |
72,957
+68,519
| +1,544% | +$10.3M |
|
160
CoStar Group
CSGP
$11.3B
| $11.2M | 0.15% |
+131,810
| New | +$10.5M |
|
161
GoodRx Holdings
GDRX
$982M
| $11.2M | 0.15% |
+201,000
| New | +$10.6M |
|
162
NVIDIA
NVDA
$5.08T
| $11.2M | 0.15% |
824,040
-1,747,760
| -68% | -$20.3M |
|
163
Armstrong World Industries
AWI
$6.86B
| $11M | 0.15% |
160,309
+106,164
| +196% | +$7.77M |
|
164
Roper Technologies
ROP
$36.2B
| $11M | 0.15% |
27,836
+3,140
| +13% | +$1.31M |
|
165
Intel
INTC
$481B
| $10.8M | 0.15% |
209,200
-239,671
| -53% | -$12.5M |
|
166
XPO
XPO
$25.1B
| $10.8M | 0.15% |
+368,034
| New | +$10.6M |
|
167
Roku
ROKU
$21.1B
| $10.8M | 0.15% |
57,008
+20,140
| +55% | +$3.18M |
|
168
Generac Holdings
GNRC
$12.2B
| $10.6M | 0.14% |
54,951
+479
| +0.9% | +$78.8K |
|
169
Southern Copper
SCCO
$142B
| $10.6M | 0.14% |
+252,843
| New | +$10.5M |
|
|
INFO
170
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $10.5M | 0.14% |
134,207
+61,100
| +84% | +$4.87M |
|
171
Evergy
EVRG
$20B
| $10.5M | 0.14% |
206,504
+196,182
| +1,901% | +$11M |
|
172
KeyCorp
KEY
$24.4B
| $10.4M | 0.14% |
872,840
+743,039
| +572% | +$9.06M |
|
|
173
Waste Management
WM
$95.5B
| $10.3M | 0.14% |
90,956
-267,805
| -75% | -$29.6M |
|
|
CERN
174
DELISTED
Cerner Corp
CERN
| $10.3M | 0.14% |
+141,800
| New | +$10.1M |
|
175
Black Hills Corp
BKH
$5.71B
| $10.2M | 0.14% |
191,372
+48,400
| +34% | +$2.76M |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.